Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2006 1
2007 1
2013 1
2019 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial.
Seekircher L, Bánki Z, Kimpel J, Rössler A, Schäfer H, Falkensammer B, Bante D, Forer L, Schönherr S; Shieldvacc-2 Study Group; Harthaller T, Sacher M, Ower C, Tschiderer L, Ulmer H, Krammer F, von Laer D, Borena W, Willeit P. Seekircher L, et al. Lancet Microbe. 2023 Aug;4(8):e612-e621. doi: 10.1016/S2666-5247(23)00107-6. Epub 2023 Jun 21. Lancet Microbe. 2023. PMID: 37354911 Free PMC article. Clinical Trial.
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro.
Lackner M, Rössler A, Volland A, Stadtmüller MN, Müllauer B, Banki Z, Ströhle J, Luttick A, Fenner J, Sarg B, Kremser L, Tone P, Stoiber H, von Laer D, Wolff T, Schwarz C, Nagl M. Lackner M, et al. Among authors: mullauer b. Emerg Microbes Infect. 2022 Dec;11(1):1293-1307. doi: 10.1080/22221751.2022.2065932. Emerg Microbes Infect. 2022. PMID: 35418279 Free PMC article.
Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.
Bánki Z, Wilflingseder D, Ammann CG, Pruenster M, Müllauer B, Holländer K, Meyer M, Sprinzl GM, van Lunzen J, Stellbrink HJ, Dierich MP, Stoiber H. Bánki Z, et al. Among authors: mullauer b. J Immunol. 2006 Sep 1;177(5):3469-76. doi: 10.4049/jimmunol.177.5.3469. J Immunol. 2006. PMID: 16920989
11 results